CLINICAL_TRIALS
trial_result
· 2023-10-11
Clinical Trial Update: Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis [NA]
Summary
Clinical trial investigating exhaled breath analysis to predict risk of symptomatic pneumonitis in patients with stage III non-small cell lung cancer; study ter…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Wake Forest University Health Sciences | Conditions: Pneumonitis, Nonsmall Cell Lung Cancer Stage III | NA | Status: TERMINATED | Results posted: 2023-10-11